DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Thursday reported fiscal fourth-quarter net income of $31.8 million.

On a per-share basis, the Danvers, Massachusetts-based company said it had profit of 70 cents. Earnings, adjusted for non-recurring costs, were $1 per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 96 cents per share.

The maker of heart devices posted revenue of $206.7 million in the period, falling short of Street forecasts. Five analysts surveyed by Zacks expected $212.2 million.

For the year, the company reported profit of $203 million, or $4.43 per share. Revenue was reported as $840.9 million.

Abiomed shares have decreased roughly 1% since the beginning of the year. The stock has decreased 38% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABMD at https://www.zacks.com/ap/ABMD

Automated Insights, source Associated Press News